AAVANTIBIO
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
AAVANTIBIO
Industry:
Biotechnology Genetics Health Care Life Science
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aavantibio.com
Total Employee:
11+
Status:
Active
Total Funding:
107 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Sitelinks Search Box Organization Schema
Similar Organizations
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Hive
Hive Biosystems helps pharmaceutical companies streamline genetics-driven drug discovery by rapidly generating transgenic animals.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_member
Board_member
2015-01-01
Current Employees Featured
David Howton Chief Operating Officer & General Counsel @ AavantiBio
Chief Operating Officer & General Counsel
Jenny Marlowe Chief Scientific Officer @ AavantiBio
Chief Scientific Officer
2021-11-01
Paul Herzich Chief Technology Officer @ AavantiBio
Chief Technology Officer
Jessie Hanrahan Chief Regulatory Officer @ AavantiBio
Chief Regulatory Officer
Douglas J. Swirsky Chief Financial Officer @ AavantiBio
Chief Financial Officer
2021-02-01
Christopher Wright Chief Medical Officer @ AavantiBio
Chief Medical Officer
2021-05-01
Bo Cumbo President & Chief Executive Officer @ AavantiBio
President & Chief Executive Officer
Founder
Investors List
RA Capital Management
RA Capital Management investment in Series A - AavantiBio
Sarepta Therapeutics
Sarepta Therapeutics investment in Series A - AavantiBio
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series A - AavantiBio
SV Health Investors
SV Health Investors investment in Series A - AavantiBio
Perceptive Advisors
Perceptive Advisors investment in Series A - AavantiBio
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-16 | AavantiBio Further Enhances Leadership Team with Appointment of Jenny Marlowe, Ph.D. as Chief Scientific Officer |
| 2021-03-30 | Aavantibio taps Wright as chief medical officer |
Official Site Inspections
http://www.aavantibio.com Semrush global rank: 1.95 M Semrush visits lastest month: 11.04 K
Unable to get host informations!!!
More informations about "AavantiBio"
AavantiBio, Inc. - LinkedIn
AavantiBio, Inc. | 4,129 followers on LinkedIn. Advancing Gene Therapy | AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors ...See details»
AavantiBio - Crunchbase Company Profile & Funding
Organization. AavantiBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. AavantiBio is a biopharmaceutical company that …See details»
AavantiBio, Inc.: Contact Details and Business Profile
AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, and RA Capital Management, who …See details»
AavantiBio 2025 Company Profile: Valuation, Investors …
AavantiBio General Information Description. Developer of a gene therapy designed to transform the lives of patients with rare genetic diseases. The …See details»
AavantiBio - Overview, News & Similar companies | ZoomInfo.com
Who is AavantiBio. AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Scie nces, and RA Capital …See details»
Solid Biosciences Announces Acquisition of AavantiBio and …
Sep 30, 2022 Solid Biosciences Inc. - Transactions to create a precision genetic medicine company focused on neuromuscular and cardiac rare diseases, led by industry veteran and …See details»
AavantiBio Company Profile - Office Locations, Competitors ... - Craft
AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space. The company focuses on hereditary genetic illnesses, such as Ataxia Friedreich …See details»
Solid Biosciences acquires AavantiBio, conducts $75 million private ...
3 days ago The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a deal which is expected to result in a combined sum of $215 …See details»
Gene Therapy Company AavantiBio Launches with $107 Million
Oct 22, 2020 AavantiBio will pursue a diversified gene therapy pipeline, ... “Bo Cumbo has built a first-in-class rare disease commercial organization and has made tremendous contributions …See details»
Solid Biosciences acquires AavantiBio - 2022-09-30 - Crunchbase
Dec 5, 2022 AavantiBio AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. Acquiring Organization: Solid …See details»
AavantiBio Company Profile | Management and Employees List
AavantiBio Profile and History. AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, …See details»
AavantiBio Announces Formation of Scientific Advisory Board
Feb 9, 2022 About AavantiBio, Inc. AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, …See details»
Gene Therapy Company AavantiBio Launches with $107 Million …
Oct 22, 2020 AavantiBio will benefit from strategic partnerships with the University of Florida’s renowned Powell Gene Therapy Center and the MDA Care Center at UF Health where Drs. …See details»
AavantiBio - Funding, Financials, Valuation & Investors - Crunchbase
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. ... Experience the new Crunchbase, powered by AI . …See details»
Sarepta helps bankroll new gene therapy startup AavantiBio
Mar 1, 2025 Sarepta chief commercial officer Bo Cumbo has left to head up gene therapy venture – AavantiBio – with $107 million in backing from his former employer and three high …See details»
AavantiBio - Contacts, Employees, Board Members, Advisors
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. ... Experience the new Crunchbase, powered by AI . …See details»
AavantiBio - Company info. interviews, news - BiopharmaTrend
May 6, 2022 AavantiBio is headquartered in Cambridge, MA with additional locations in Gainesville, FL. Posts Mentioning This Company. 7 Biotechs Fighting Rare Diseases With …See details»
Customer Story | AavantiBio - ZenQMS
Biotech company AavantiBio shuns large, expensive software companies in favor of ZenQMS to power its quality management system. ... “Making software fit-for-purpose for your own …See details»
Gene Therapy Company AavantiBio Launches With $107 ... - UF …
Oct 22, 2020 A premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, and RA Capital Management, together with Sarepta Therapeutics, Inc., …See details»
AavantiBio and Resilience Announce Strategic Collaboration for …
Jun 3, 2021 AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, and RA Capital …See details»